Evaluation of the effectiveness of topiramate in treating dependence of amphetamine and methamphetamine patients
Phase 2
Recruiting
- Conditions
- drug abuse.F19Other psyc
- Registration Number
- IRCT20160417027437N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients aged 18-55 years
With amphetamine and methamphetamine use disorders
Exclusion Criteria
History of major psychiatric disorder
existence of harmful thoughts to oneself and others
history of receiving psychiatric medication during the last 3 months
pregnant woman or breast feeding
BMI less than 18
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of dependence. Timepoint: Weeks 2, 4, 6, 8, 10 and 12 after the intervention. Method of measurement: McLellan Dependency Index Questionnaire.
- Secondary Outcome Measures
Name Time Method Depression. Timepoint: Weeks 2, 4, 6, 8, 10 and 12 after the intervention. Method of measurement: Beck Depression Inventory.